Some drugs make it and some don’t, while there may still be hope for physicians referring patients with hearing loss. In the end, we have a good reason to rant even more than usual and so John and Dean end happy.
A condensed version of AudiologyTalk covers industry news, gene therapy, and whether a legal firm can force insurance companies to cover hearing instruments. We finish with a super rare sighting of two co-hosts without a single thought to discuss.
We we don’t personally subscribe to anything having to do with preparation or forethought when podcasting, John and Dean recognize the value of promoting prevention in an audiology practice and discuss some ideas you can use during Protect Your Hearing month (that’s October, by the way).
Our first guest in a while may also be one of our most important ever, as we discuss one of the most fundamental aspects of clinical practice: infection control. This is the episode you want to hear, share, and maybe even take notes about!
We look at an update to the National Academies of Science position on OTC hearing aids, a new 3M hearing conversation web site and a possible new otoprotective drug. Plus, audiologists talking about socialized medicine? WHAT?!
After a mega-podcast on OTC, we discuss how this may affect audiology, as well as “other” professions. Also, exciting new research on regenerating hair cells and other audiology research and news.
In this extra-long episode, John and Dean catch up on the current news and research since our last episode and thoroughly explore the content and implications of the OTC hearing aid bill currently in Congress.
Dr. Gail Whitelaw of Ohio State University and Dr. Lindsey Jorgesen of the University of South Dakota join John and Jenne for a thorough discussion of practice standards, best practices, and standards of care for audiology. You don’t want to miss this engaging talk that might actually change the profession!
Special guest host Jenne(fer) Tunnell joins John this year for our annual recordings at the American Academy of Audiology’s annual conference. We focus on Tinnitus with guests from the American Tinnitus Association and British Tinnitus Association discussing how patients and providers can access their services and materials. We also have a special conversation with Dr. David Baguley from the University of Nottingham about professional practice with tinnitus patients.
We start the new year Mindy-less, but John and Dean cover some intriguing news and, in true form, take a discussion somewhere it was never meant to go and probably should never go again.
We discuss new research in pediatric cisplatin therapy and Meniere’s Disease treatment. Meanwhile, one of the audiology organizations finally steps up and proclaims the benefits of audiology care and IHS stumbles all over itself in an attempt to tell audiologists they were wrong to oppose the federal Department of Labor training dispensers on procedures outside their scope of practice.
John and Dean focus on professional issues which seem to be arising all around us recently. In addition, we perform a little self-examination about our own biases, although not too much. That would probably hurt.
Breaking news about a new oto-antibiotic and the best gene every for deafness. Plus, we catch up on birthdays and proceed without Mindy to keep us in check, which causes John to rant about just about everybody who irks us. The one organization we didn’t talk bad about? ASHA! Go figure.
After an extended summer break, Dean, Mindy, and John are back for your listening pleasure – or detriment. We catch up on a few months of news and birthdays and ask the question of the year: Are hearing instruments being treated as consumer electronic devices?
We close out the conference with a big student episode. We are joined by the SAA President and President-Elect and play our second annual game of AudiologyTalk Senseless Trivia. Listen and find out who took home the trophy this year!